Skip to content

Sleep apnoea study ‘milestone’ for treatment access

A new sleep apnoea device from medical device company Imthera Medical will be tested on its first two patients. The patients have been implanted with the company’s Aura6000 system as part of a randomised, controlled, prospective, multicentre clinical trial being conducted in the US and Europe. ‘Too many patients are left untreated or undertreated by … Continued